ClinicalTrials.Veeva

Menu

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia

H

HaEmek Medical Center, Israel

Status

Completed

Conditions

Sickle Cell Thalassemia
Sickle Cell Anemia

Treatments

Other: Laboratory analyses of iron overload

Study type

Observational

Funder types

Other

Identifiers

NCT00512564
0087-07-EMC

Details and patient eligibility

About

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't developed significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpose of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and laboratory studies including Non Transferrin Binding Iron, Labile Iron and Hepcidin, in order to determine the cardiac and liver iron.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All the patients with Sickle Cell Anemia and Sickle Cell Thalassemia that are treated and followed up at the Pediatric Hematology Unit.

Trial design

50 participants in 1 patient group

1
Description:
Patients suffering from Sickle cell disease
Treatment:
Other: Laboratory analyses of iron overload

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems